ARS PHARMACEUTICALS INC
SPRY·82835W108·US·Common Stock·Healthcare - Biotechnology-Activist
SPRY (ARS PHARMACEUTICALS INC) is held by 105 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($87.2M), MILLENNIUM MANAGEMENT LLC ($48M), BlackRock, Inc. ($40.2M). Net institutional sentiment: Mixed.
105
Holders
Avg rating(23 Elite)
$425.1M
Total Value
51% (114)
Fund Consensus
52 buying - 49 selling
Who's Trading
ActivistRURubric Capital Management LP8.1%May 15, 2026
InsiderDBDorsey BrianSell $190KNov 13, 2025
InsiderCJChakma JustinSell $267KNov 12, 2025
InsiderCJChakma JustinSell $1.2MNov 12, 2025
InsiderLELowenthal Richard ESell $724KAug 21, 2025
InsiderSDScott Kathleen D.Sell $188KAug 21, 2025
13F: Insider & Congress:
Showing 1-20 of 114
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer